Resilient Lifescience
Pittsburgh · Founded 2022
About Resilient Lifescience
Resilient Lifescience develops a wearable medical device to prevent opioid overdose deaths using naloxone.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $625.0K
- Funding stage: Seed
- Last round: Pre-Seed (Dec 2023)
- Website: https://www.resilient.bio/
Industries & Categories
Life Science, Medical Device, Therapeutics, Wearables
Social Profiles
Canonical: https://fsome.com/organization/resilient-lifescience-136665 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.